Comparison BridgeBio Pharma (BBIO) with Competitors
BridgeBio Pharma (BBIO) industry is Biotechnology.
Profit Margin
BBIO-85.63%
Industry-0.13%
Upside-85.50%
Operating Margin
BBIO-54.47%
Industry-2073.25%
Upside+2018.78%
Debt-to-Equity
BBIO-116.44%
Industry29.76%
Upside-146.20%
Free Cash Flow Yield
BBIO-3.42%
Industry-1.94%
Upside-1.48%
P/E
BBIO-17.62
Industry-18.88
Upside+126.28%
P/S
BBIO22.38
Industry9.28
Upside+141.11%
P/B
BBIO123.68
Industry4.70
Upside+2532.91%